Toru Yamano
Takeda Pharmaceutical Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Toru Yamano.
Tetrahedron Letters | 1999
Toru Yamano; Naohiro Taya; Mitsuru Kawada; Taisheng Huang; Tsuneo Imamoto
Abstract Asymmetric hydrogenation of keto esters using a BisP ∗ RuBr 2 catalyst is reported. High enantioselectivities up to 98% were achieved in the hydrogenation of β-keto esters.
Tetrahedron-asymmetry | 2003
Tatsuya Ito; Tomomi Ikemoto; Toru Yamano; Yukio Mizuno; Kiminori Tomimatsu
Abstract A practical method for the preparation of ( R )-(+)-6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-hydroxyphenyl)hexanoic acid ( R )- 2 , a key intermediate for a therapeutic drug for neurodegenerative diseases, has been developed. rac -Methyl 6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-(propionyloxy)phenyl) hexanoate rac - 9b was synthesized from 2-methylnaphthoquinone in seven steps. An optically active ester ( R )- 9b was readily obtained from the corresponding racemic ester by lipase-catalyzed resolution, followed by sulfation or phosphorylation. Sulfation by a sulfur trioxide pyridine complex or phosphorylation by phosphoryl chloride enabled facile isolation of the optically active ester simply by extraction. Optically active acid ( R )- 2 was synthesized in excellent enantiomeric excess by hydrolysis of ( R )- 9b followed by recrystallization. The present synthesis of ( R )- 2 was accomplished in 10 steps without requiring chromatographic purification.
Bioorganic & Medicinal Chemistry Letters | 2011
Tohru Yamashita; Makoto Kamata; Satoshi Endo; Mitsuo Yamamoto; Keiko Kakegawa; Hiroyuki Watanabe; Katsuhiko Miwa; Toru Yamano; Masaaki Funata; Jyunichi Sakamoto; Akiyoshi Tani; Clifford D. Mol; Hua Zou; Douglas R. Dougan; Bi-Ching Sang; Gyorgy Snell; Kohji Fukatsu
The co-crystal structure of the human acetyl-coenzyme A 2 (ACC2) carboxyl transferase domain and the reported compound CP-640186 (1b) suggested that two carbonyl groups are essential for potent ACC2 inhibition. By focusing on enhancing the interactions between the two carbonyl groups and the amino acid residues Gly(2162) and Glu(2230), we used ligand- and structure-based drug design to discover spirolactones bearing a 2-ureidobenzothiophene moiety.
Heterocycles | 1993
Toru Yamano; Mitsutaka Tanaka; Kunio Takanohashi
An efficient preparation of a d-biotin intermediate, (±)-(3aα,4α,6aα)-1,3-dibenzyl-3a,4,6,6a-tetrahydro-4-hydroxy-1H-thieno[3,4-d]imidazol-2(3H)-one was accomplished by use of 1,3-cycloaddition of a thiocarbonyl ylide, Curtius rearrangement and sila-Pummerer rearrangement. Addition of p-toluenesulfonic acid was found to be effective to promote sila-Pummerer rearrangement of sterically unfavorable anti-2-trimethylsilyl sulfoxide
Organic Letters | 2002
Akio Ojida; Toru Yamano; Naohiro Taya; Akihiro Tasaka
Journal of Medicinal Chemistry | 2002
Kohji Fukatsu; Osamu Uchikawa; Mitsuru Kawada; Toru Yamano; Masayuki Yamashita; Koki Kato; Keisuke Hirai; Shuji Hinuma; Masaomi Miyamoto; Shigenori Ohkawa
Tetrahedron-asymmetry | 2006
Toru Yamano; Masayuki Yamashita; Mari Adachi; Mitsutaka Tanaka; Kiyoharu Matsumoto; Mitsuru Kawada; Osamu Uchikawa; Kohji Fukatsu; Shigenori Ohkawa
Chemical & Pharmaceutical Bulletin | 2006
Masami Yamada; Takashi Ichikawa; Toru Yamano; Fumio Kikumoto; Yuji Nishikimi; Norikazu Tamura; Tomoyuki Kitazaki
Chemistry Letters | 2000
Toru Yamano; Fumio Kikumoto; Shozo Yamamoto; Katsuhiko Miwa; Mitsuru Kawada; Tatsuya Ito; Tomomi Ikemoto; Kiminori Tomimatsu; Yukio Mizuno
Archive | 2000
Isao Aoki; Mari Adachi; Mitsuru Kawada; Toru Yamano; Naohiro Taya